Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4523350 Target Snapshot

NAD(+) hydrolase SARM1 · SINGLE PROTEIN · Homo sapiens

47Compounds
20Assays
5Approved Drugs
23.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q6SZW1. Use UniProt Q6SZW1 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q6SZW1 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats NAD(+) hydrolase SARM1 as ChEMBL target CHEMBL4523350, mapped to UniProt Q6SZW1. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
NAD(+) hydrolase SARM1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4523350
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q6SZW1
NAD(+) hydrolase SARM1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether NAD(+) hydrolase SARM1 is the right protein anchor across sources, using UniProt Q6SZW1 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNAD(+) hydrolase SARM1
UniProt AccessionQ6SZW1
Component TypeProtein
Sequence Length724 aa

NAD(+) hydrolase SARM1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as NAD(+) hydrolase SARM1, mapped to UniProt Q6SZW1. Sequence length is 724 aa.

Mapped IDQ6SZW1
Review nameNAD(+) hydrolase SARM1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

5
Approved
1
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC5019.0
KI4.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2009370 6.82 IC50 150.0 Preclinical
CHEMBL2009483 6.16 IC50 700.0 Preclinical
CHEMBL1219 5.5 IC50 3200.0 Approved
CHEMBL1201863 5.48 IC50 3300.0 Approved
CHEMBL1475252 5.13 IC50 7400.0 Clinical
CHEMBL4458111 4.67 IC50 21400.0 Preclinical
CHEMBL1140 4.36 IC50 43800.0 Approved
CHEMBL1201022 4.16 Ki 70000.0 Approved
CHEMBL12089 4.11 IC50 77000.0 Preclinical
CHEMBL869 4.05 IC50 90000.0 Approved
Distribution

pChEMBL Value Distribution

5
5.0
1
5.5
1
6.0
1
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

20
Total Assays
12
Tested Compounds
1
Assay Types
Binding — 20 assays, 12 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 13 7 5.3
subcellular format 6 4 4.1
single protein format 1 1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine